NCT07608484

Brief Summary

The endotracheal tube is one of the medical devices most associated with pressure injuries related to medical devices. This study aims to evaluate the effectiveness of applying a silicone foam dressing over the endotracheal tube and repositioning the endotracheal tube in preventing endotracheal tube-related pressure injuries in patients receiving mechanical ventilation support.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
15mo left

Started Jun 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
Jun 2026Aug 2027

First Submitted

Initial submission to the registry

May 13, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 27, 2026

Completed
5 days until next milestone

Study Start

First participant enrolled

June 1, 2026

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2027

Last Updated

June 2, 2026

Status Verified

May 1, 2026

Enrollment Period

1.2 years

First QC Date

May 13, 2026

Last Update Submit

May 30, 2026

Conditions

Keywords

Pressure injuryIntensive care unitEndotracheal tubePrevention

Outcome Measures

Primary Outcomes (1)

  • Assessment of whether a ETT related oral mucosa pressure injury develop

    Endotracheal Tube-Related Pressure Injury Assessment Form

    From intubation until the end of follow-up, up to 14 days.

Study Arms (3)

Group 1

EXPERIMENTAL

Use of silicone foam dressing and repositioning every 8 hours

Other: Use of silicone foam dressing and repositioning every 8 hours

Group 2

ACTIVE COMPARATOR

Repositioning every 8 hours

Other: Repositioning every 8 hours

Group 3

NO INTERVENTION

Standard care (Control Group)

Interventions

Patients assigned to this group will receive a silicone foam dressing applied over the endotracheal tube, with repositioning performed every 8 hours. As the silicone foam wound dressing, AQUACEL™ Foam, a sterile, waterproof dressing consisting of a polyurethane outer film layer and a multilayer absorbent pad with silicone adhesive borders, will be used.

Group 1

In patients assigned to this group, the initial repositioning following intubation and the first assessment of the lips, oral cavity, and perioral skin and mucosa will be performed 8 hours after intubation. If the endotracheal tube (ETT) is positioned at the right or left corner of the mouth, it will be repositioned to the midline; if it is positioned at the midline, it will be repositioned to either the right or left corner of the mouth. Following the initial repositioning, subsequent repositioning procedures will be performed every 8 hours.

Group 2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or older
  • Patients admitted to the General Intensive Care Unit and receiving mechanical ventilation support
  • Absence of pressure injuries, other lesions, or anomalies on the inner and outer surfaces of the lips and at the oral commissures prior to intubation
  • Absence of congenital anomalies that could interfere with the assessment of pressure injuries on the inner and outer surfaces of the lips and at the oral commissures

You may not qualify if:

  • Receiving mechanical ventilation support initiated prior to admission to the intensive care unit
  • Undergoing nasotracheal intubation
  • History of any intraoral surgical procedure
  • Presence of a contraindication to repositioning of the endotracheal tube
  • More than one hour having elapsed since intubation (for Group 1)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pressure Ulcer

Condition Hierarchy (Ancestors)

Skin UlcerSkin DiseasesSkin and Connective Tissue Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

May 13, 2026

First Posted

May 27, 2026

Study Start

June 1, 2026

Primary Completion (Estimated)

August 30, 2027

Study Completion (Estimated)

August 30, 2027

Last Updated

June 2, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share